Meta-analysis of 9 RCTs (1251 patients) of remimazolam vs midazolam for GI endoscopy sedation: no significant difference in sedation success (RR 1.49; P=.08), but faster induction and recovery and less hypotension and bradycardia; heterogeneity was substantial.
Meta-analysisn = 1,251
Akram et al. Remimazolam versus midazolam for moderate sedation in gastrointestinal endoscopy: a systematic review and meta-analysis of randomized controlled trials